US biopharma: 221 drugs now in R&D for diabetes, related conditions

They include 32 new treatments for type 1 diabetes, 130 for type 2, 14 for unspecified diabetes and 64 for diabetes-related conditions, says PhRMA, which describes this pipeline as “an exciting new chapter in the ongoing quest to better treat this debilitating disease.”

Read more

Posted in Type I Type II Drugs